한국어
Quantus

Generate Biomedicines, Inc. Common Stock

GENB · Nasdaq
$13.80-8.12%
2026-10-01 close · prelim

Generate Biomedicines, Inc. Common Stock last closed at $13.80 (-8.12%) on 2026-10-01. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
297 picks
Next-day win rate
47.2%
Avg next-day
-0.20%
vs market
-0.12%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

More — deeper indicators

Connections

AI-extracted related companies · for reference

Customers
Novo NordiskNovartisSanofiRocheAmgenPfizerEli Lilly
Competitors
GenentechAbCellera BiologicsAdimab
Same theme
Flagship PioneeringSchrödingerRecursion PharmaceuticalsXaira Therapeutics
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Generate Biomedicines, Inc. Common Stock
What technical signals does Generate Biomedicines, Inc. Common Stock (GENB) have?
Generate Biomedicines, Inc. Common Stock current technical signals: no active technical signal.
Is Generate Biomedicines, Inc. Common Stock a cup-and-handle pattern?
No. Generate Biomedicines, Inc. Common Stock has no valid cup-and-handle signal right now.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy